135 related articles for article (PubMed ID: 36308390)
1. Biallelic GTF2IRD1 variants in brothers with profound neurodevelopmental disorder: A possible novel disorder involving a critical gene for Williams syndrome.
Cummings CT; Starr LJ
Am J Med Genet A; 2023 Feb; 191(2):332-337. PubMed ID: 36308390
[TBL] [Abstract][Full Text] [Related]
2. RNA-Seq analysis of Gtf2ird1 knockout epidermal tissue provides potential insights into molecular mechanisms underpinning Williams-Beuren syndrome.
Corley SM; Canales CP; Carmona-Mora P; Mendoza-Reinosa V; Beverdam A; Hardeman EC; Wilkins MR; Palmer SJ
BMC Genomics; 2016 Jun; 17():450. PubMed ID: 27295951
[TBL] [Abstract][Full Text] [Related]
3. Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations.
Howard ML; Palmer SJ; Taylor KM; Arthurson GJ; Spitzer MW; Du X; Pang TY; Renoir T; Hardeman EC; Hannan AJ
Neurobiol Dis; 2012 Mar; 45(3):913-22. PubMed ID: 22198572
[TBL] [Abstract][Full Text] [Related]
4. Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism.
Palmer SJ; Santucci N; Widagdo J; Bontempo SJ; Taylor KM; Tay ES; Hook J; Lemckert F; Gunning PW; Hardeman EC
J Biol Chem; 2010 Feb; 285(7):4715-24. PubMed ID: 20007321
[TBL] [Abstract][Full Text] [Related]
5. The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.
Vandeweyer G; Van der Aa N; Reyniers E; Kooy RF
Am J Hum Genet; 2012 Jun; 90(6):1071-8. PubMed ID: 22608712
[TBL] [Abstract][Full Text] [Related]
6. Anxious, hypoactive phenotype combined with motor deficits in Gtf2ird1 null mouse model relevant to Williams syndrome.
Schneider T; Skitt Z; Liu Y; Deacon RM; Flint J; Karmiloff-Smith A; Rawlins JN; Tassabehji M
Behav Brain Res; 2012 Aug; 233(2):458-73. PubMed ID: 22652393
[TBL] [Abstract][Full Text] [Related]
7. The role of GTF2IRD1 in the auditory pathology of Williams-Beuren Syndrome.
Canales CP; Wong AC; Gunning PW; Housley GD; Hardeman EC; Palmer SJ
Eur J Hum Genet; 2015 Jun; 23(6):774-80. PubMed ID: 25248400
[TBL] [Abstract][Full Text] [Related]
8. Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.
Antonell A; Del Campo M; Magano LF; Kaufmann L; de la Iglesia JM; Gallastegui F; Flores R; Schweigmann U; Fauth C; Kotzot D; Pérez-Jurado LA
J Med Genet; 2010 May; 47(5):312-20. PubMed ID: 19897463
[TBL] [Abstract][Full Text] [Related]
9. A role for transcription factor GTF2IRD2 in executive function in Williams-Beuren syndrome.
Porter MA; Dobson-Stone C; Kwok JB; Schofield PR; Beckett W; Tassabehji M
PLoS One; 2012; 7(10):e47457. PubMed ID: 23118870
[TBL] [Abstract][Full Text] [Related]
10. Extensive characterization of a Williams syndrome murine model shows Gtf2ird1-mediated rescue of select sensorimotor tasks, but no effect on enhanced social behavior.
Nygaard KR; Maloney SE; Swift RG; McCullough KB; Wagner RE; Fass SB; Garbett K; Mirnics K; Veenstra-VanderWeele J; Dougherty JD
Genes Brain Behav; 2023 Aug; 22(4):e12853. PubMed ID: 37370259
[TBL] [Abstract][Full Text] [Related]
11. Exome sequencing of 85 Williams-Beuren syndrome cases rules out coding variation as a major contributor to remaining variance in social behavior.
Kopp ND; Parrish PCR; Lugo M; Dougherty JD; Kozel BA
Mol Genet Genomic Med; 2018 Sep; 6(5):749-765. PubMed ID: 30008175
[TBL] [Abstract][Full Text] [Related]
12. Atypical deletion of Williams-Beuren syndrome reveals the mechanism of neurodevelopmental disorders.
Zhou J; Zheng Y; Liang G; Xu X; Liu J; Chen S; Ge T; Wen P; Zhang Y; Liu X; Zhuang J; Wu Y; Chen J
BMC Med Genomics; 2022 Apr; 15(1):79. PubMed ID: 35379245
[TBL] [Abstract][Full Text] [Related]
13. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
Franke Y; Peoples RJ; Francke U
Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
[TBL] [Abstract][Full Text] [Related]
14. GTF2IRD2 is located in the Williams-Beuren syndrome critical region 7q11.23 and encodes a protein with two TFII-I-like helix-loop-helix repeats.
Makeyev AV; Erdenechimeg L; Mungunsukh O; Roth JJ; Enkhmandakh B; Ruddle FH; Bayarsaihan D
Proc Natl Acad Sci U S A; 2004 Jul; 101(30):11052-7. PubMed ID: 15243160
[TBL] [Abstract][Full Text] [Related]
15. Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.
Kopp N; McCullough K; Maloney SE; Dougherty JD
Hum Mol Genet; 2019 Oct; 28(20):3443-3465. PubMed ID: 31418010
[TBL] [Abstract][Full Text] [Related]
16. Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development.
Palmer SJ; Tay ES; Santucci N; Cuc Bach TT; Hook J; Lemckert FA; Jamieson RV; Gunnning PW; Hardeman EC
Gene Expr Patterns; 2007 Feb; 7(4):396-404. PubMed ID: 17239664
[TBL] [Abstract][Full Text] [Related]
17. Global analysis of gene expression in the developing brain of Gtf2ird1 knockout mice.
O'Leary J; Osborne LR
PLoS One; 2011; 6(8):e23868. PubMed ID: 21909369
[TBL] [Abstract][Full Text] [Related]
18. Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome.
van Hagen JM; van der Geest JN; van der Giessen RS; Lagers-van Haselen GC; Eussen HJ; Gille JJ; Govaerts LC; Wouters CH; de Coo IF; Hoogenraad CC; Koekkoek SK; Frens MA; van Camp N; van der Linden A; Jansweijer MC; Thorgeirsson SS; De Zeeuw CI
Neurobiol Dis; 2007 Apr; 26(1):112-24. PubMed ID: 17270452
[TBL] [Abstract][Full Text] [Related]
19. A transcriptomic study of Williams-Beuren syndrome associated genes in mouse embryonic stem cells.
De Cegli R; Iacobacci S; Fedele A; Ballabio A; di Bernardo D
Sci Data; 2019 Nov; 6(1):262. PubMed ID: 31695049
[TBL] [Abstract][Full Text] [Related]
20. Innate frequency-discrimination hyperacuity in Williams-Beuren syndrome mice.
Davenport CM; Teubner BJW; Han SB; Patton MH; Eom TY; Garic D; Lansdell BJ; Shirinifard A; Chang TC; Klein J; Pruett-Miller SM; Blundon JA; Zakharenko SS
Cell; 2022 Oct; 185(21):3877-3895.e21. PubMed ID: 36152627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
